Evaluation of biomarkers for cardiotoxicity of anthracyclin-based chemotherapy

INTRODUCTION: The clinical assessment of the myocardial damage caused by anthracyclin (ANT)-therapy is difficult. Therefore a study was performed to evaluate non-invasive markers of anthracyclin-induced cardiac effects, with emphasis on course-to-course variation. METHODS: Eligible for study partici...

Descripción completa

Detalles Bibliográficos
Autores principales: Broeyer, F. J. F., Osanto, S., Ritsema van Eck, H. J., van Steijn, A. Q. M. J., Ballieux, B. E. P. B., Schoemaker, R. C., Cohen, A. F., Burggraaf, J.
Formato: Texto
Lenguaje:English
Publicado: Springer-Verlag 2008
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2515587/
https://www.ncbi.nlm.nih.gov/pubmed/18343950
http://dx.doi.org/10.1007/s00432-008-0372-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2515587/
https://www.ncbi.nlm.nih.gov/pubmed/18343950
http://dx.doi.org/10.1007/s00432-008-0372-8

Ejemplares similares